Condition: Prostate Cancer · Erectile Dysfunction Following Radiation Therapy · Sponsor: UMC Utrecht
Single-arm phase II trial of 70 men with low- or intermediate-risk prostate cancer receiving magnetic resonance guided adaptive radiotherapy (MRgRT) in 5 fractions of 7.25 Gy, additionally sparing the neurovascular bundles, the internal pudendal arteries, the corpora cavernosa, and the penile bulb for erectile function preservation.
This description comes directly from the study's public registry record.
Frederik R Teunissen, MD · +31 (0)887550474 · f.r.teunissen@umcutrecht.nl
Jochem RN van der Voort van Zyp, MD PhD · j.r.n.vandervoortvanzyp@umcutrecht.nl
Always discuss trial participation with your own doctor first.
| University Medical Center Utrecht | Utrecht, Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04861194